Origin Pharma: Revolutionising the Pharmaceutical Industry

HULL, U.K. - June 24, 2016 - PRLog -- HP³ is born into the modern Pharmaceutical Market where competition is accelerating due to scientific and technological innovations both within and outside the sector.  It's born into a client pool which is concerned to remain relevant and increase momentum, whilst ensuring that the attributes critical to the successful delivery of health and well-being remain intact. It's born into the only market where speed and perfection are fundamental to success.

Hybrid Pharma Packaging Partner (HP³) is a change programme designed to accelerate the competitiveness of the pharmaceutical primary packaging industry by raising the performance of its supply chains.   International competition, together with the challenges posed by government legislation, necessitates rapid improvement in the effectiveness of the industry's supply chain.

Keith Wade of Origin explains why HP³ is becoming a critical aspect of the top 25 pharmaceutical companies supply chains. "Since 2010 we've been developing a supply chain solution alongside key stakeholders in the top 10.  The presence of disruptive improvements to the value chain in bordering markets lead us to challenge the constraints within the pharmaceutical market we serve.  Historically, speed to market was not considered to be negotiable, in fact statistics show it takes an average of 10 years to bring a new drug product to the market.   We border Electronics (an industry category with a comparable spend in R&D) where it takes an average of 12 weeks to develop a new app. HP³ facilitates the evolving migration of certain factors across to our industry." He goes onto describe and compare why HP³ will drive efficiency and improve profits, "Our clients realise that the effectiveness of the supply chain in for example the Aerospace industry is an essential attainment in order to remain competitive.  Although diverse, both examples reference some essential processes applicable to all markets. A new drug product won't be developed in 12 weeks but applying effective methodology which combines speed, leadership and flexibility minimises the development time and cost to bring your brand safely to market."

HP³ compiles three facets of the pharmaceutical primary packaging function. Design and Development, Strategic Manufacturing and Supply Chain Consolidation - giving the client the ability to use the HP³ full process from concept to fulfilment or utilise the aspects applicable to their current requirements. For example, Origin Pharma assist large pharma companies with their supply chain, by consolidating both suppliers and processes (sourcing raw materials, streamlining transport etc) to reduce cost, improve profitability and drive efficiency.

Through the securing of dedicated manufacturing and storage facilities in strategic locations across multiple countries, we remain within a short distance of our clients' bases of operation. HP3 also removes manufacturing constraints and allows unlimited access to approved production sites, which encompass all manufacturing techniques. So, no matter what the job, we can deliver to precise specifications and a strict deadline.

Hybrid Pharma Packaging Partner is a new model, which respects the critical nature of quality control, regulatory compliance and change management, yet alleviates traditional constraints. It is born of the frustrations of industry stakeholders wanting to pioneer improvements from speed to market to a streamlined supply chain. HP³ is stimulating the pharmaceutical market, galvanising developments within the top 10 and will is a guaranteed challenger to the 'norm'.

UBER are now offering pharmaceutical giants a lift….

richard.quelch@originltd.com

01482 638380

www.originltd.com

http://www.originltd.com/hp3/hp3

Availability - Mon to Fri, 9am to 5pm

Extra info:

What are the benefits of partnering with HP3?

HP3 encompasses a large range of benefits, key examples being:

    Global choice, through exposure to multiple manufacturing capabilities

    Leading edge project developments through a solution based approach to challenges not biased towards single site capabilities

    Superior outcomes via the combination of multiple disciplines with limited stakeholders

    Increased competitiveness through fast track developments

    Increased efficiency in speed to market

    Operational excellence and reduced TCO (total cost of ownership)

    Reduced overheads through implementing business excellence and lean principles

    Local availability via regional DC's

    Reduced risk through increased contingency options

    Increased dominance and brand exposure through 'core purpose' oriented productivity

    Strategic Production - we're never far away!

    Strategy relationships via supplier consolidation

    Assurance of supply via quality qualified relationships